243 related articles for article (PubMed ID: 15066321)
1. Heterogeneity of structural abnormalities in the 7q31.3 approximately q34 region in myeloid malignancies.
González MB; Gutiérrez NC; García JL; Schoenmakers EF; Solé F; Calasanz MJ; San Miguel JF; Hernández JM
Cancer Genet Cytogenet; 2004 Apr; 150(2):136-43. PubMed ID: 15066321
[TBL] [Abstract][Full Text] [Related]
2. Structural aberrations of chromosome 7 revealed by a combination of molecular cytogenetic techniques in myeloid malignancies.
Brezinová J; Zemanová Z; Ransdorfová S; Pavlistová L; Babická L; Housková L; Melichercíková J; Sisková M; Cermák J; Michalová K
Cancer Genet Cytogenet; 2007 Feb; 173(1):10-6. PubMed ID: 17284364
[TBL] [Abstract][Full Text] [Related]
3. Loss of genetic material is more common than gain in acute myeloid leukemia with complex aberrant karyotype: a detailed analysis of 125 cases using conventional chromosome analysis and fluorescence in situ hybridization including 24-color FISH.
Schoch C; Haferlach T; Bursch S; Gerstner D; Schnittger S; Dugas M; Kern W; Löffler H; Hiddemann W
Genes Chromosomes Cancer; 2002 Sep; 35(1):20-9. PubMed ID: 12203786
[TBL] [Abstract][Full Text] [Related]
4. [Molecular cytogenetic analysis of -7/7q- abnormalities in patients with myeloid malignancies].
Xiao Y; Liu SH; Liu XP; Qin S; Bo LJ; Li CW; Dai Y; Wang JS
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Dec; 20(6):471-6. PubMed ID: 14669212
[TBL] [Abstract][Full Text] [Related]
5. [Abnormalities of chromosome 17 in myeloid malignancies with complex chromosomal abnormalities].
Zhu Y; Xu W; Liu Q; Pan J; Qiu H; Wang R; Qiao C; Jiang Y; Zhang S; Fan L; Zhang J; Shen Y; Xue Y; Li J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):579-82. PubMed ID: 18841577
[TBL] [Abstract][Full Text] [Related]
6. Spectral karyotyping in patients with acute myeloid leukemia and a complex karyotype shows hidden aberrations, including recurrent overrepresentation of 21q, 11q, and 22q.
Mrózek K; Heinonen K; Theil KS; Bloomfield CD
Genes Chromosomes Cancer; 2002 Jun; 34(2):137-53. PubMed ID: 11979548
[TBL] [Abstract][Full Text] [Related]
7. Several chromosomes involved in translocations with chromosome 5 shown with fluorescence in situ hybridization in patients with malignant myeloid disorders.
Bram S; Rödjer S; Swolin B
Cancer Genet Cytogenet; 2004 Nov; 155(1):74-8. PubMed ID: 15527906
[TBL] [Abstract][Full Text] [Related]
8. Analysis of balanced rearrangements of chromosome 6 in acute leukemia: clustered breakpoints in q22-q23 and possible involvement of c-MYB in a new recurrent translocation, t(6;7)(q23;q32 through 36).
Sinclair P; Harrison CJ; Jarosová M; Foroni L
Haematologica; 2005 May; 90(5):602-11. PubMed ID: 15921375
[TBL] [Abstract][Full Text] [Related]
9. Molecular cytogenetic delineation of deletions and translocations involving chromosome band 7q22 in myeloid leukemias.
Fischer K; Fröhling S; Scherer SW; McAllister Brown J; Scholl C; Stilgenbauer S; Tsui LC; Lichter P; Döhner H
Blood; 1997 Mar; 89(6):2036-41. PubMed ID: 9058725
[TBL] [Abstract][Full Text] [Related]
10. Classification of deletions and identification of cryptic translocations involving 7q by fluorescence in situ hybridization (FISH).
Tosi S; Harbott J; Haas OA; Douglas A; Hughes DM; Ross FM; Biondi A; Scherer SW; Kearney L
Leukemia; 1996 Apr; 10(4):644-9. PubMed ID: 8618441
[TBL] [Abstract][Full Text] [Related]
11. Molecular cytogenetic profiling of complex karyotypes in primary myelodysplastic syndromes and acute myeloid leukemia.
Trost D; Hildebrandt B; Beier M; Müller N; Germing U; Royer-Pokora B
Cancer Genet Cytogenet; 2006 Feb; 165(1):51-63. PubMed ID: 16490597
[TBL] [Abstract][Full Text] [Related]
12. Delineation of multiple deleted regions in 7q in myeloid disorders.
Tosi S; Scherer SW; Giudici G; Czepulkowski B; Biondi A; Kearney L
Genes Chromosomes Cancer; 1999 Aug; 25(4):384-92. PubMed ID: 10398433
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the human myeloid leukemia-derived cell line GF-D8 by multiplex fluorescence in situ hybridization, subtelomeric probes, and comparative genomic hybridization.
Tosi S; Giudici G; Rambaldi A; Scherer SW; Bray-Ward P; Dirscherl L; Biondi A; Kearney L
Genes Chromosomes Cancer; 1999 Mar; 24(3):213-21. PubMed ID: 10451701
[TBL] [Abstract][Full Text] [Related]
14. Chromosome 1 abnormalities in multiple myeloma.
Marzin Y; Jamet D; Douet-Guilbert N; Morel F; Le Bris MJ; Morice P; Abgrall JF; Berthou C; De Braekeleer M
Anticancer Res; 2006; 26(2A):953-9. PubMed ID: 16619492
[TBL] [Abstract][Full Text] [Related]
15. Systematic screening at diagnosis of -5/del(5)(q31), -7, or chromosome 8 aneuploidy by interphase fluorescence in situ hybridization in 110 acute myelocytic leukemia and high-risk myelodysplastic syndrome patients: concordances and discrepancies with conventional cytogenetics.
Beyer V; Castagné C; Mühlematter D; Parlier V; Gmür J; Hess U; Kovacsovics T; Meyer-Monard S; Tichelli A; Tobler A; Jacky E; Schanz U; Bargetzi M; Hagemeijer A; de Witte T; van Melle G; Jotterand M
Cancer Genet Cytogenet; 2004 Jul; 152(1):29-41. PubMed ID: 15193439
[TBL] [Abstract][Full Text] [Related]
16. The human Penumbra gene is mapped to a region on chromosome 7 frequently deleted in myeloid malignancies.
Chen Z; Pasquini M; Hong B; DeHart S; Heikens M; Tsai S
Cancer Genet Cytogenet; 2005 Oct; 162(2):95-8. PubMed ID: 16213355
[TBL] [Abstract][Full Text] [Related]
17. A narrow deletion of 7q is common to HCL, and SMZL, but not CLL.
Andersen CL; Gruszka-Westwood A; Østergaard M; Koch J; Jacobsen E; Kjeldsen E; Nielsen B
Eur J Haematol; 2004 Jun; 72(6):390-402. PubMed ID: 15128417
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetic and fluorescence in situ hybridization characterization of chromosome 1 rearrangements in head and neck carcinomas delineate a target region for deletions within 1p11-1p13.
Jin Y; Jin C; Wennerberg J; Mertens F; Höglund M
Cancer Res; 1998 Dec; 58(24):5859-65. PubMed ID: 9865746
[TBL] [Abstract][Full Text] [Related]
19. Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome-acute myeloid leukemia actually differ?
Lessard M; Hélias C; Struski S; Perrusson N; Uettwiller F; Mozziconacci MJ; Lafage-Pochitaloff M; Dastugue N; Terré C; Brizard F; Cornillet-Lefebvre P; Mugneret F; Barin C; Herry A; Luquet I; Desangles F; Michaux L; Verellen-Dumoulin C; Perrot C; Van den Akker J; Lespinasse J; Eclache V; Berger R;
Cancer Genet Cytogenet; 2007 Jul; 176(1):1-21. PubMed ID: 17574959
[TBL] [Abstract][Full Text] [Related]
20. Refinement of the commonly deleted segment in myeloid leukemias with a del(20q).
Wang PW; Iannantuoni K; Davis EM; Espinosa R; Stoffel M; Le Beau MM
Genes Chromosomes Cancer; 1998 Feb; 21(2):75-81. PubMed ID: 9491317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
